Enanta Pharmaceuticals, Inc.
Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
Last updated:
Abstract:
The present invention provides compounds of Formula I, ##STR00001## pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.
Status:
Application
Type:
Utility
Filling date:
26 Feb 2021
Issue date:
26 Aug 2021